Principles of Screening - The Health Radar
- Goal: Detect potential disease in asymptomatic individuals for early intervention.
- Core Principles (Wilson-Jungner Criteria):
- Disease: Important health problem with a known natural history.
- Test: Suitable, acceptable, reliable, and cost-effective.
- Treatment: Effective and available treatment for the condition.
- System: Benefits of early detection must outweigh harms like over-diagnosis.
⭐ Screening is susceptible to lead-time bias (survival appears longer due to earlier diagnosis) and length-time bias (detecting more slow-growing, less aggressive cases).
Screening Program Criteria - The Wilson-Jungner Checklist
This checklist outlines prerequisites for a viable screening program, addressing both the disease and the test.
| Criteria Related to the Disease | Criteria Related to the Test & Program |
|---|---|
| * Important Health Problem: High prevalence/morbidity. | * Suitable & Acceptable Test: Must be accurate, safe, and well-tolerated by the population. |
| * Known Natural History: The progression from preclinical to clinical disease must be understood. | * Effective Treatment: An accepted treatment must be available that improves outcomes when started early. |
| * Detectable Preclinical Phase: A long latent period or early symptomatic stage must exist. | * Cost-Effective: The overall benefits must outweigh the costs of screening, diagnosis, and treatment. |
| * Continuous Process: Screening must be ongoing, not a one-time campaign. |
Screening Metrics & Biases - De-biasing the Numbers
- Screening Metrics: Evaluates test accuracy against a gold standard.
- Sensitivity: $TP / (TP + FN)$
- Ability to correctly identify those with the disease.
- 📌 SNOUT: High Sensitivity test, when Negative, rules OUT disease.
- Specificity: $TN / (TN + FP)$
- Ability to correctly identify those without the disease.
- 📌 SPIN: High Specificity test, when Positive, rules IN disease.
- PPV (Positive Predictive Value): $TP / (TP + FP)$
- NPV (Negative Predictive Value): $TN / (TN + FN)$
- Sensitivity: $TP / (TP + FN)$

⭐ ↑ Prevalence → ↑ PPV & ↓ NPV. Sensitivity and specificity are intrinsic test characteristics and do not change with prevalence.
- Screening Biases:
- Lead-Time Bias: Early detection artificially inflates survival time, but the course of the disease and time of death are unchanged.
- Length-Time Bias: Screening is more likely to detect slow-growing, indolent cases, which naturally have a better prognosis.
- Selection (Volunteer) Bias: Participants in screening studies are often healthier than the general population, skewing results toward better outcomes.
High‑Yield Points - ⚡ Biggest Takeaways
- Screening is for asymptomatic individuals; it is not diagnostic.
- The condition should be an important health problem with a long preclinical phase.
- An effective and acceptable treatment must be available.
- The screening test must be sensitive, specific, safe, and affordable.
- Beware of lead-time bias (earlier detection artificially inflates survival) and length-time bias (detecting more slow-growing, benign cases).
Continue reading on Oncourse
Sign up for free to access the full lesson, plus unlimited questions, flashcards, AI-powered notes, and more.
CONTINUE READING — FREEor get the app